Latest Insider Transactions at Revolution Medicines, Inc. (RVMD)
This section provides a real-time view of insider transactions for Revolution Medicines, Inc. (RVMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revolution Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revolution Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Mark A Goldsmith |
BUY
Grant, award, or other acquisition
|
Direct |
104,000
+35.79%
|
-
|
|
Dec 17
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
1,571
-1.87%
|
$37,704
$24.41 P/Share
|
|
Dec 17
2021
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
491
-1.89%
|
$11,784
$24.41 P/Share
|
|
Dec 17
2021
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
343
-0.14%
|
$8,232
$24.41 P/Share
|
|
Dec 17
2021
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
257
-2.11%
|
$6,168
$24.41 P/Share
|
|
Dec 17
2021
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
170
-1.98%
|
$4,080
$24.41 P/Share
|
|
Dec 06
2021
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
37,721
+30.94%
|
$0
$0.49 P/Share
|
|
Sep 17
2021
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
479
-1.81%
|
$14,370
$30.02 P/Share
|
|
Sep 17
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
1,531
-3.19%
|
$45,930
$30.02 P/Share
|
|
Sep 17
2021
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
250
-2.01%
|
$7,500
$30.02 P/Share
|
|
Sep 17
2021
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
335
-0.13%
|
$10,050
$30.02 P/Share
|
|
Sep 17
2021
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
166
-1.99%
|
$4,980
$30.02 P/Share
|
|
Jun 22
2021
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+6.78%
|
-
|
|
Jun 22
2021
|
Barbara Weber |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+40.0%
|
-
|
|
Jun 22
2021
|
Elizabeth M Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+40.0%
|
-
|
|
Jun 22
2021
|
Eric Thomas Schmidt |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+25.0%
|
-
|
|
Jun 22
2021
|
Flavia Borellini |
BUY
Grant, award, or other acquisition
|
Direct |
7,234
+50.0%
|
-
|
|
Jun 22
2021
|
Neil Exter Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+13.28%
|
-
|
|
Jun 22
2021
|
Vincent A. Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+13.22%
|
-
|
|
Jun 17
2021
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
160
-1.88%
|
$5,440
$34.12 P/Share
|
|
Jun 17
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
1,485
-1.5%
|
$49,005
$33.82 P/Share
|
|
Jun 17
2021
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
464
-1.72%
|
$15,776
$34.13 P/Share
|
|
Jun 17
2021
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
324
-0.13%
|
$11,016
$34.12 P/Share
|
|
Jun 17
2021
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
243
-1.92%
|
$8,262
$34.12 P/Share
|
|
Jun 04
2021
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 04
2021
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
164,996
-100.0%
|
$4,949,880
$30.23 P/Share
|
|
Jun 03
2021
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 03
2021
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
378,117
-69.62%
|
$11,343,510
$30.2 P/Share
|
|
May 26
2021
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
May 26
2021
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,231,204
-69.39%
|
$36,936,120
$30.53 P/Share
|
|
May 25
2021
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
May 25
2021
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
135,000
-7.07%
|
$4,050,000
$30.93 P/Share
|
|
Apr 28
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
100
-0.0%
|
$4,200
$42.5 P/Share
|
|
Apr 27
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
23,326
-0.69%
|
$979,692
$42.65 P/Share
|
|
Apr 26
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
52,984
-1.55%
|
$2,225,328
$42.85 P/Share
|
|
Apr 09
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
24,701
-0.72%
|
$1,062,143
$43.83 P/Share
|
|
Apr 08
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
46,228
-1.32%
|
$2,034,032
$44.8 P/Share
|
|
Apr 07
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
27,953
-0.79%
|
$1,257,885
$45.6 P/Share
|
|
Apr 06
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
39,500
-1.11%
|
$1,896,000
$48.06 P/Share
|
|
Apr 05
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
18,215
-0.51%
|
$837,890
$46.65 P/Share
|
|
Mar 22
2021
|
Vincent A. Miller Director |
SELL
Open market or private sale
|
Direct |
3,200
-13.71%
|
$156,800
$49.0 P/Share
|
|
Mar 22
2021
|
Vincent A. Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,200
+12.06%
|
$12,800
$4.73 P/Share
|
|
Mar 04
2021
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
11,200
+48.39%
|
-
|
|
Mar 04
2021
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,400
+48.35%
|
-
|
|
Mar 04
2021
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+5.62%
|
-
|
|
Mar 04
2021
|
Mark A Goldsmith |
BUY
Grant, award, or other acquisition
|
Direct |
48,000
+49.62%
|
-
|
|
Mar 04
2021
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+36.41%
|
-
|
|
Mar 01
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
5,000
-87.05%
|
$230,000
$46.0 P/Share
|
|
Mar 01
2021
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+46.54%
|
$5,000
$1.12 P/Share
|
|
Feb 24
2021
|
Neil Exter Director |
SELL
Other acquisition or disposition
|
Indirect |
0
|
-
|